MRK · News · 20261103N
Guidance and Outlook
Merck & Co., Inc. · 2026-11-03 · Importance 75 · Surprise 60 · In source text
A third-party article reported that Merck raised its full-year 2026 sales guidance to $66.8 billion–$67.3 billion. Another article reported a mid-2030s revenue target of $70 billion. The digest does not provide further details on the timing or assumptions underlying that longer-term target.
Key facts
- Merck reported third-quarter sales of US$18.1 billion and raised full-year 2026 sales guidance to US$66.8 billion to US$67.3 billion. source
- Merck set a mid-2030s revenue target of $70 billion. source
- A third-party article said Merck had posted its sixth consecutive earnings beat and raised its 2026 profit outlook. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | committed | — | Merck reported third-quarter sales of US$18.1 billion and raised full-year 2026 sales guidance to US$66.8 billion to US$67.3 billion. |
| revenue | positive | contingent | — | Merck set a mid-2030s revenue target of $70 billion. |